Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction. [electronic resource]
Producer: 20180815ISSN:- 1573-4935
- Aged
- Aspirin -- administration & dosage
- Cerebral Infarction -- blood
- Cholesterol -- blood
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Drug Combinations
- Female
- Humans
- Male
- Middle Aged
- Recombinant Proteins -- administration & dosage
- Tissue Plasminogen Activator -- administration & dosage
- Triglycerides -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.